Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03375112 · ClinicalTrials.gov registry record · Phase 4
Fascia Iliaca Blocks for Pain Control After Total Hip Arthroplasty
A Phase 4 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 122
- Enrollment target
NCT03375112 is a Phase 4 study that has completed, run by Henry Ford Health System. The registered enrollment target is 122 participants.
The verdict
NCT03375112, a Phase 4 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 122 participants
- Enrollment target
Study Summary
The fascia iliaca compartment block (FICB) is a regional block that anesthetizes the femoral, obturator, and lateral femoral cutaneous nerves around the hip. The purpose of this study is to determine whether FICB can reduce postoperative pain and increase progress with physical therapy after total hip arthroplasty (THA). This randomized, double-blind, clinical trial will randomize patients to receive either a FICB or placebo after THA. The primary outcomes will be pain scores reported by the patient post-operatively.
Interventions
- DRUG Placebo
- DRUG Bupivacaine
- PROCEDURE Fascia iliaca compartment block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2017-07-31 |
| Est. Completion | 2019-10-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03375112
The ClinicalTrials.gov registry entry for NCT03375112 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT03375112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03375112 about?
NCT03375112 is a clinical study titled "Fascia Iliaca Blocks for Pain Control After Total Hip Arthroplasty". The fascia iliaca compartment block (FICB) is a regional block that anesthetizes the femoral, obturator, and lateral femoral cutaneous nerves around the hip. The purpose of this study is to determine whether FICB can reduce postoperative pain and increase progress with physical therapy after total h...
What is the current status of trial NCT03375112?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 122 participants. The study started on 2017-07-31. Estimated completion is 2019-10-01.
What interventions are being tested in trial NCT03375112?
The interventions under investigation include: Placebo (DRUG), Bupivacaine (DRUG), Fascia iliaca compartment block (PROCEDURE).
Who is sponsoring clinical trial NCT03375112?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.